Market Tracker

05/26 10:33am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

15.99
BATS BZX Real-Time Price
As of 10:31am ET
 -0.11 / -0.68%
Today’s Change
13.58
Today|||52-Week Range
32.49
-33.82%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close16.10
Today’s open16.14
Day’s range15.89 - 16.14
Volume5,862
Average volume (3 months)950,487
Market cap$619.8M
Dividend yield--
Data as of 10:31am ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.16-1.48%
CLVSClovis Oncology Inc+0.21+1.31%
KERXKeryx Biopharmaceuti...-0.02-0.35%
CORTCorcept Therapeutics...-0.07-1.28%
Data as of 10:33am ET, 05/26/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts